Switzerland / Upcoming Cost Containment Packages: Industry Key Concerns
While once considered the land of milk and honey within Europe in terms of market access and reimbursement for…
Top Stories
Southeast Asia / Kalbe Underwhelms in Indonesia; Novavax Looks to Filipino Vaccine Manufacturing; Thai Cannabis Market Boom
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Development & Manufacturing / Newly Independent CDMO Skyepharma Looks to Expansion
Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director…
MEA / Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in Saudi
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA)…
In Conversation
Georg Schroeckenfuchs – President & Cluster Head MEA, Novartis
Georg Schroeckenfuchs, Novartis’ president and head of the Middle East and Africa (MEA) cluster, explains how the company’s objectives are aligned with Saudi Arabia’s Vision 2030, the progress made towards the nationalization of its Saudi workforce, the potential impact of changes in the tender process, and why Novartis is uniquely positioned to build on Saudi Arabia’s clinical trial capabilities. …
Latest Reports
Focus on China
HKEX’s Aim to Become World’s #1 Biotech Listing Hub…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s…
Roche Hoping to Spearhead ‘Created in China’ Push with…
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai,…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
APAC: Generic Penetration by Country
Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3…
Read more: China >>
Focus on Europe
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Spanish Pharma News: Market Growth; Esteve’s US Expansion;…
The latest from Spanish pharma, including the acquisition of PTS by a private…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Read more: Europe >>
Focus on Switzerland
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical…
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
Read more: Switzerland >>
Focus on Singapore
APAC: Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Varian’s Kenneth Tan on the Future of Cancer Care in…
Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
Read more: Singapore >>
Focus on USA
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
US U-Turn as Biden Pledges Support for Waiver on COVID-19…
In a shock move, Joe Biden’s administration looks set to support a waiver on…
If the “Primary Endpoint” in an…
Taking the example of music's effect on Alzheimer's disease patients, John G…
US Generics & Biosimilars: Five Takeaways from Access!…
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five…
Read more: USA >>
Focus on Vaccines
IP PACT: A Journey, Not a Destination
The issue of COVID-19 vaccine access in developing nations has thrust…
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more…
Sputnik V: A Brief History of Russia’s Controversial Viral…
Although Russian authorities received heavy criticism for approving the Sputnik…
Southeast Asia: Kalbe Underwhelms in Indonesia; Novavax…
The latest from the pharma industry in Southeast Asia, including underwhelming…
Read more: Vaccines >>
Focus on MEA
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
The Skills That Regional Pharma Leaders Need in the Middle…
Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa…
Georg Schroeckenfuchs of Novartis: ‘Shooting for the…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…